1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metabolomics Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Targeted Metabolomics Service
1.2.3 Untargeted Metabolomics Service
1.3 Market by Application
1.3.1 Global Metabolomics Services Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Biomarker Discovery
1.3.3 Drug Discovery
1.3.4 Toxicological Testing
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Metabolomics Services Market Perspective (2017-2028)
2.2 Metabolomics Services Growth Trends by Region
2.2.1 Metabolomics Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Metabolomics Services Historic Market Size by Region (2017-2022)
2.2.3 Metabolomics Services Forecasted Market Size by Region (2023-2028)
2.3 Metabolomics Services Market Dynamics
2.3.1 Metabolomics Services Industry Trends
2.3.2 Metabolomics Services Market Drivers
2.3.3 Metabolomics Services Market Challenges
2.3.4 Metabolomics Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metabolomics Services Players by Revenue
3.1.1 Global Top Metabolomics Services Players by Revenue (2017-2022)
3.1.2 Global Metabolomics Services Revenue Market Share by Players (2017-2022)
3.2 Global Metabolomics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metabolomics Services Revenue
3.4 Global Metabolomics Services Market Concentration Ratio
3.4.1 Global Metabolomics Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolomics Services Revenue in 2021
3.5 Metabolomics Services Key Players Head office and Area Served
3.6 Key Players Metabolomics Services Product Solution and Service
3.7 Date of Enter into Metabolomics Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metabolomics Services Breakdown Data by Type
4.1 Global Metabolomics Services Historic Market Size by Type (2017-2022)
4.2 Global Metabolomics Services Forecasted Market Size by Type (2023-2028)
5 Metabolomics Services Breakdown Data by Application
5.1 Global Metabolomics Services Historic Market Size by Application (2017-2022)
5.2 Global Metabolomics Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Metabolomics Services Market Size (2017-2028)
6.2 North America Metabolomics Services Market Size by Country (2017-2022)
6.3 North America Metabolomics Services Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Metabolomics Services Market Size (2017-2028)
7.2 Europe Metabolomics Services Market Size by Country (2017-2022)
7.3 Europe Metabolomics Services Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metabolomics Services Market Size (2017-2028)
8.2 Asia-Pacific Metabolomics Services Market Size by Country (2017-2022)
8.3 Asia-Pacific Metabolomics Services Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Metabolomics Services Market Size (2017-2028)
9.2 Latin America Metabolomics Services Market Size by Country (2017-2022)
9.3 Latin America Metabolomics Services Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metabolomics Services Market Size (2017-2028)
10.2 Middle East & Africa Metabolomics Services Market Size by Country (2017-2022)
10.3 Middle East & Africa Metabolomics Services Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 BASF SE
11.1.1 BASF SE Company Detail
11.1.2 BASF SE Business Overview
11.1.3 BASF SE Metabolomics Services Introduction
11.1.4 BASF SE Revenue in Metabolomics Services Business (2017-2022)
11.1.5 BASF SE Recent Development
11.2 TMIC
11.2.1 TMIC Company Detail
11.2.2 TMIC Business Overview
11.2.3 TMIC Metabolomics Services Introduction
11.2.4 TMIC Revenue in Metabolomics Services Business (2017-2022)
11.2.5 TMIC Recent Development
11.3 Creative Proteomics
11.3.1 Creative Proteomics Company Detail
11.3.2 Creative Proteomics Business Overview
11.3.3 Creative Proteomics Metabolomics Services Introduction
11.3.4 Creative Proteomics Revenue in Metabolomics Services Business (2017-2022)
11.3.5 Creative Proteomics Recent Development
11.4 BGI
11.4.1 BGI Company Detail
11.4.2 BGI Business Overview
11.4.3 BGI Metabolomics Services Introduction
11.4.4 BGI Revenue in Metabolomics Services Business (2017-2022)
11.4.5 BGI Recent Development
11.5 RTI International
11.5.1 RTI International Company Detail
11.5.2 RTI International Business Overview
11.5.3 RTI International Metabolomics Services Introduction
11.5.4 RTI International Revenue in Metabolomics Services Business (2017-2022)
11.5.5 RTI International Recent Development
11.6 Afekta Technologies
11.6.1 Afekta Technologies Company Detail
11.6.2 Afekta Technologies Business Overview
11.6.3 Afekta Technologies Metabolomics Services Introduction
11.6.4 Afekta Technologies Revenue in Metabolomics Services Business (2017-2022)
11.6.5 Afekta Technologies Recent Development
11.7 Fred Hutchinson Cancer Research Center
11.7.1 Fred Hutchinson Cancer Research Center Company Detail
11.7.2 Fred Hutchinson Cancer Research Center Business Overview
11.7.3 Fred Hutchinson Cancer Research Center Metabolomics Services Introduction
11.7.4 Fred Hutchinson Cancer Research Center Revenue in Metabolomics Services Business (2017-2022)
11.7.5 Fred Hutchinson Cancer Research Center Recent Development
11.8 West Coast Metabolomics Center
11.8.1 West Coast Metabolomics Center Company Detail
11.8.2 West Coast Metabolomics Center Business Overview
11.8.3 West Coast Metabolomics Center Metabolomics Services Introduction
11.8.4 West Coast Metabolomics Center Revenue in Metabolomics Services Business (2017-2022)
11.8.5 West Coast Metabolomics Center Recent Development
11.9 Molecular You
11.9.1 Molecular You Company Detail
11.9.2 Molecular You Business Overview
11.9.3 Molecular You Metabolomics Services Introduction
11.9.4 Molecular You Revenue in Metabolomics Services Business (2017-2022)
11.9.5 Molecular You Recent Development
11.10 Metabolon
11.10.1 Metabolon Company Detail
11.10.2 Metabolon Business Overview
11.10.3 Metabolon Metabolomics Services Introduction
11.10.4 Metabolon Revenue in Metabolomics Services Business (2017-2022)
11.10.5 Metabolon Recent Development
11.11 Biocrates Life sciences
11.11.1 Biocrates Life sciences Company Detail
11.11.2 Biocrates Life sciences Business Overview
11.11.3 Biocrates Life sciences Metabolomics Services Introduction
11.11.4 Biocrates Life sciences Revenue in Metabolomics Services Business (2017-2022)
11.11.5 Biocrates Life sciences Recent Development
11.12 Chenomx
11.12.1 Chenomx Company Detail
11.12.2 Chenomx Business Overview
11.12.3 Chenomx Metabolomics Services Introduction
11.12.4 Chenomx Revenue in Metabolomics Services Business (2017-2022)
11.12.5 Chenomx Recent Development
11.13 C-CAMP
11.13.1 C-CAMP Company Detail
11.13.2 C-CAMP Business Overview
11.13.3 C-CAMP Metabolomics Services Introduction
11.13.4 C-CAMP Revenue in Metabolomics Services Business (2017-2022)
11.13.5 C-CAMP Recent Development
11.14 MetaSysX
11.14.1 MetaSysX Company Detail
11.14.2 MetaSysX Business Overview
11.14.3 MetaSysX Metabolomics Services Introduction
11.14.4 MetaSysX Revenue in Metabolomics Services Business (2017-2022)
11.14.5 MetaSysX Recent Development
11.15 MS-Omics
11.15.1 MS-Omics Company Detail
11.15.2 MS-Omics Business Overview
11.15.3 MS-Omics Metabolomics Services Introduction
11.15.4 MS-Omics Revenue in Metabolomics Services Business (2017-2022)
11.15.5 MS-Omics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
